PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Sci Transl Med. Author manuscript; available in PMC 2017 September 20.
Published in final edited form as:
PMCID: PMC5606244
NIHMSID: NIHMS904948

Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis

Abstract

The regenerative capacity of lung and liver is sometimes impaired by chronic or overwhelming injury. Orthotopic transplantation of parenchymal stem cells to damaged organs might reinstate their self-repair ability. However, parenchymal cell engraftment is frequently hampered by the microenvironment in diseased recipient organs. Here, we show that targeting both the vascular niche and perivascular fibroblasts establishes “hospitable soil” to foster incorporation of “seed”, in this case the engraftment of parenchymal cells in injured organs. Specifically, ectopic induction of endothelial cell (EC)-expressed paracrine/angiocrine hepatocyte growth factor (HGF) and inhibition of perivascular NADPH Oxidase 4 (NOX4) synergistically enabled reconstitution of mouse and human parenchymal cells in damaged organs. Reciprocally, genetic knockout of Hgf in mouse ECs (HgfiΔEC/iΔEC) aberrantly upregulated perivascular NOX4 during liver and lung regeneration. Dysregulated HGF and NOX4 pathways subverted the function of vascular and perivascular cells from an epithelially-inductive niche to a microenvironment that inhibited parenchymal reconstitution. Perivascular NOX4 induction in HgfiΔEC/iΔEC mice recapitulated the phenotype of human and mouse fibrotic livers and lungs. Consequently, EC-directed HGF and NOX4 inhibitor GKT137831 stimulated regenerative integration of mouse and human parenchymal cells in chronically injured lung and liver. Our data suggest that targeting dysfunctional perivascular and vascular cells in diseased organs can bypass fibrosis and enable reparative cell engraftment to reinstate lung and liver regeneration.

Introduction

The self-repair capacity of liver and lung tissue is sometimes prohibited by overwhelming or persistent injury (119). Transplantation of parenchymal stem cells might aid in reinstating the regenerative ability (2038), but efficient engraftment of parenchymal cells is handicapped by the prohibitive fibrotic microenvironment in diseased organs. Therefore, designing effective cell therapy strategies requires understanding how microenvironmental cues regulate parenchymal regeneration and fibrosis in the damaged lung and liver (3947).

Surgical resection of liver or lung lobes by partial hepatectomy (PH) or pneumonectomy (PNX) triggers facultative regeneration without fibrosis (4852). Liver and lung can also resolve fibrosis after acute injury (5355). In contrast, chronic injury stimulates exuberant scar formation and fibrosis, leading to hepatic and pulmonary failure (5663). How fibrosis is resolved after PH, PNX, or acute injury but triggered by chronic or overwhelming injury remains incompletely known (6466). Since fibroblasts are the major cell type that produces matrix proteins during scar formation (59, 6769), we hypothesized that modulating the interplay between perivascular fibroblasts and endothelial cells (ECs) might obviate fibrosis in the liver (2, 48, 49, 52) and lung (47, 7073), forming an epithelially-inductive niche for parenchymal cell reconstitution and regeneration (74, 75).

Here we find that EC-expressed HGF prevents aberrant activation of NADPH Oxidase 4 (NOX4) (56, 76, 77) in perivascular fibroblasts after lung and liver injury. Induction of HGF and inhibition of NOX4 in damaged organs promotes the incorporation of regenerative parenchymal cells. We also devised a strategy to edit both vascular and perivascular cells by combining endothelial Hgf gene delivery with NOX4 inhibition. This dual niche-editing strategy enhanced functional reconstitution of mouse and human parenchymal cells, inducing fibrosis-free organ repair. Our data suggest that targeting vascular and perivascular cells in diseased organs might transform the prohibitive microenvironment to an epithelially-inductive niche that bypasses fibrosis and facilitates engraftment of regenerative progenitor cells.

Results

Repeated lung and liver injuries prohibit the incorporation of grafted parenchymal cells

We first tested the efficiency of parenchymal cell engraftment in both normal and injured mouse lung and liver. Non-injured and injured lungs were transplanted with type 2 alveolar epithelial cells (AEC2s), cells that contribute to lung epithelialization (14, 21, 24, 26) (Fig. 1A–B, fig. S1A), and livers were grafted with hepatocytes mediating hepatic reconstitution (27, 33, 78) (Fig. 1C–D, fig. S1B). Lung injury was induced by intratracheal injection of bleomycin (Bleo) or hydrochloric acid (Acid) (46), and liver repair was triggered by intraperitoneal injection of carbon tetrachloride (CCl4). To trace in vivo incorporation of transplanted parenchymal cells, AEC2-specific surfactant protein C-CreERT2 (Sftpc-CreERT2) mice (14) and hepatocyte-specific Albumin-Cre mice were bred with TdTomato reporter mice. Isolated TdTomato+ AEC2 or hepatocytes were transplanted into mice via intratracheal or intrasplenic injection, respectively. We found that there was little parenchymal cell incorporation in the non-injured lung or liver (fig. S1A, B). In contrast, AEC2s and hepatocytes integrated into the injured lung or liver after the 3rd Bleo, Acid or CCl4 injection (Fig. 1B, D).

Fig. 1
EC-produced HGF promotes reconstitution of transplanted parenchymal cells in the injured lung and liver in mice

Injured lung and liver either undergo fibrosis-free repair or develop fibrosis. A single Bleo or Acid injection triggers re-epithelialization in the injured lung without triggering fibrosis, but fibrosis starts to occur after repetitive injury (15). Similarly, CCl4 injection stimulates hepatic regeneration after three injections, but the injured liver ceases to resolve fibrosis after multiple CCl4 injections (16). Indeed, parenchymal cells failed to incorporate into the liver and lung after more than six injections of Bleo, Acid, or CCl4 (Fig. 1B, D, fig. S1C), the stage at which injured liver and lung developed fibrosis (fig. S1D, E).

EC-produced HGF mitigates expression of pro-fibrotic NOX4 protein in perivascular fibroblasts

We then defined the microenvironment-derived cues that foster the incorporation of transplanted hepatocytes and AEC2s. Vascular ECs lining liver sinusoids or pulmonary capillaries were shown to elicit parenchymal regeneration (2, 16, 52, 79, 80). EC-produced HGF stimulates proliferation of parenchymal cells for organ repair (16, 48, 8083). Thus, we tested whether endothelial HGF influences parenchymal cell engraftment. Mice expressing EC-specific VE-cadherin-driven CreERT2 (Cdh5-(PAC)-CreERT2) (84) were bred with floxed Hgf mice (Fig. 1E). Mice were injected with tamoxifen to induce EC-specific ablation of Hgf (HgfiΔEC/iΔEC), and EC-specific Hgf heterozygous knockout (HgfiΔEC/+) mice were used as controls (fig. S2A).

Lung and liver repair were analyzed in HgfiΔEC/iΔEC and control mice after the 3rd Bleo or CCl4 injection (Fig. 1E). Compared with control mice, there was increased lethality in HgfiΔEC/iΔEC mice after liver or lung injury, which was associated with elevated tissue destruction and increased fibrosis in HgfiΔEC/iΔEC liver and lung (Fig. 1F–I, fig. S2B–C). Consequently, incorporation of transplanted parenchymal cells was suppressed in the injured HgfiΔEC/iΔEC lung or liver, as compared with than that of controls (Fig. 1J, K). Hence, EC-produced HGF promotes organ repair, resolves fibrosis, and facilitates the engraftment of parenchymal cells in the injured lung and liver.

HgfiΔEC/iΔEC mice were then characterized in another liver regeneration model induced by PH. Qualitative immunostaining analysis suggested that hepatocyte proliferation after PH was lower in HgfiΔEC/iΔEC mice than controls (Fig. 2A), and collagen deposition and cell apoptosis were elevated in the liver of hepatectomized HgfiΔEC/iΔEC mice compared to controls (Fig. 2B–C). Immunostaining and ELISA analysis of Malondialdehyde (MDA) revealed markedly higher peroxide formation in HgfiΔEC/iΔEC mouse liver after PH (Fig. 2D–E). Hepatectomized HgfiΔEC/iΔEC mice also exhibited increased lethality and liver damage than controls, as evidenced by higher serum bilirubin concentration (fig. S2D–E). Thus, HGF expressed by ECs stimulates parenchymal cell expansion and resolves fibrosis during PH-induced liver regeneration.

Figure 2
HGF from ECs reduces NADPH Oxidase 4 (NOX4) expression in perivascular fibroblasts to bypass fibrosis during liver regeneration

Increased fibrosis and oxidative damage in HgfiΔEC/iΔEC mice led us to identify the influence of endothelial HGF on perivascular fibroblasts. HGF was shown to attenuate the expression of the NOX family of proteins that regulate redox balance (85), and elevated NOX activity after injury stimulates fibrosis (56, 76). Indeed, after PH and three CCl4 injections, NOX4 expression was increased in the liver of HgfiΔEC/iΔEC mice than that of controls (Fig. 2F–H). Furthermore, NOX4 protein was found to be preferentially distributed in perivascular fibroblasts of hepatectomized HgfiΔEC/iΔEC mice (Fig. 2I). As such, development of fibrosis in HgfiΔEC/iΔEC mice in liver regeneration is associated with NOX4 induction in perivascular fibroblasts.

To establish the correlation between endothelial HGF and perivascular NOX4 in fibrogenesis, we adopted a liver-specific gene transduction system (86). Bolus injection of a large volume of gene material via tail vein caused gene transduction in the mouse liver (fig. S2F). This system allowed us to study the contribution of Nox4 to liver regeneration in HgfiΔEC/iΔEC mice. Silencing Nox4 expression in hepatectomized or CCl4-injured HgfiΔEC/iΔEC mice promoted liver regeneration and blocked fibrosis (fig. S2G–J). Thus, endothelial HGF stimulates fibrosis-free liver repair at least partially by suppressing NOX4 upregulation in perivascular fibroblasts.

We then sought to define the hepatic-protective effect of endothelial HGF in a liver cholestasis model, bile duct ligation (BDL). The common bile duct was ligated and resected to induce biliary epithelial injury. BDL caused perivascular NOX4 protein upregulation and stimulated qualitatively higher degrees of cell apoptosis, peroxide formation, and collagen deposition in HgfiΔEC/iΔEC livers than controls (Fig. 2J–O, fig. S2K). As such, loss of HGF expression in EC might stimulate perivascular fibroblast activation in cirrhotic liver.

The clinical relevance of the HGF-NOX4 axis was investigated in samples of liver from human cirrhotic patients. Immunostaining of NOX4 and desmin showed that the extent of fibrosis positively correlated with NOX4 protein expression in the cirrhotic livers (Fig. 3A). NOX4 was qualitatively upregulated in perivascular desmin+ fibroblasts adjacent to VE-cadherin+ ECs (Fig. 3B–D, fig. S3A–H). Thus, NOX4 upregulation in perivascular fibroblasts of injured HgfiΔEC/iΔEC liver was reminiscent of aberrant expression of perivascular NOX4 in human cirrhotic livers.

Figure 3
EC-expressed HGF abrogates pro-fibrotic NOX4 induction in human perivascular fibroblasts

Since tumor growth factor-β (TGF-β) stimulates NOX4 expression in fibroblasts (56, 76), we investigated whether endothelial HGF influences NOX4 expression in fibroblasts in the presence of TGF-β. Human and mouse hepatic stellate cells were treated with TGF-β with or without HGF. HGF ameliorated NOX4 expression and activity in human and mouse stellate cells after TGF-β stimulation (Fig. 3E–F, fig. S3I–J). An endothelial-stellate cell co-culture system was used to explore the crosstalk between endothelial HGF and fibroblast NOX4 (Fig. 3G). NOX4 protein expression was lower in stellate cells cultured with ECs overexpressing HGF (ECHGF) than those with control ECs with scrambled sequence (ECSrb) (Fig. 3H–J).

Targeting vascular and perivascular cells improves the engraftment of mouse and human parenchymal cells in fibrotic livers

Building on the finding that endothelial HGF promotes liver regeneration, we postulated that ectopic expression of HGF in the liver ECs (8789) could enhance hepatocyte engraftment in the injured liver. To test this hypothesis, we adopted a pseudotyped lentivirus system that conjugates with immunoglobulin antibody at the viral surface (90). Coupling of pseudotyped lentivirus with antibody recognizing EC antigen CD31 allows for gene transfer in ECs (15). Mouse CD31 antibody (Mec13.3) was conjugated with virus encoding green fluorescent protein (Gfp), scrambled sequence (Srb), or Hgf, resulting in Mec13-Gfp, Mec13-Srb, and Mec13-Hgf viruses.

Intra-splenic injection was employed to localize Mec13-virus in the hepatic vascular bed. Compared to control (Mec13-Srb), Mec13-Hgf attenuated perivascular NOX4 expression in BDL-injured liver (Fig. 4A–B, fig. S4A). Subsequently, we tested whether combining Mec13-Hgf with NOX4 inhibitor GKT137831 (GKT) would more efficiently provoke regeneration in the injured liver. GKT was administered to injured mice together with Mec13-Hgf (Mec13-Hgf + GKT). Mec13-Hgf + GKT substantially lowered peroxide formation and hydroxyproline amounts after BDL, more than any other tested treatments (Fig. 4C–E). Moreover, Mec13-Hgf + GKT efficiently promoted the incorporation of grafted mouse hepatocytes (Fig. 4F) and induced the most efficacious hepatic repair in all tested approaches (Fig. 4G–I).

Figure 4
Expression of HGF in liver ECs cooperates with NOX4 inhibition to enhance engraftment of regenerative hepatocytes

We then tested how dual niche-editing influences reconstitution of human hepatocytes (Fig. 5A). Immunodeficient NOD-Prkdcem26Cd52Il2rgem26Cd22/Nju (NCG) mice treated with Mec13-Srb, Mec13-Hgf, GKT, or Mec13-Hgf + GKT after BDL. Human hepatocytes were transplanted into the injured mice via intrasplenic injection. Mec13-Hgf + GKT enhanced the incorporation of GFP-labeled human hepatocytes in the damaged liver, and these grafted hepatocytes maintained the expression of hepatocyte marker cholesterol 7alpha-hydroxylase (CYP7A1) (Fig. 5B). NCG mice treated with Mec13-Hgf + GKT + human hepatocytes showed reduced cell death in the liver, regenerated hepatic architecture and function, and higher serum human albumin concentration than all other test groups (Fig. 5C–G, fig. S4B). Therefore, dual editing of vascular and perivascular cells bypasses fibrosis to enable the engraftment of mouse and human parenchymal cells, promoting hepatic regeneration (Fig. 5H).

Figure 5
Dual editing of endothelial and perivascular cells promotes incorporation of regenerative human hepatocytes in the liver

Endothelial HGF suppresses pro-fibrotic expression of NOX4 in perivascular lung fibroblasts

To explore the generality of the observed regenerative effect of endothelial HGF, we tested HgfiΔEC/iΔEC mice in a lung alveolar regeneration model triggered by PNX. PNX stimulates functional growth of the intact right lung lobe after surgical resection of the left lung lobe (Fig. 6A). Compared to the controls, HgfiΔEC/iΔEC mice had increased peroxide formation and NOX4 protein expression after PNX (Fig. 6B–C), which was accompanied by inhibited restoration of lung mass and function, and qualitatively elevated cell apoptosis (fig. S5A–D). Notably, NOX4 was qualitatively upregulated in perivascular fibroblasts in pneumonectomized HgfiΔEC/iΔEC mice (Fig. 6D). Hence, endothelial HGF has a similarly important role in driving lung alveolar regeneration and obviating fibrosis after PNX.

Figure 6
EC-expressed HGF stimulates lung alveolar regeneration and resolves fibrosis

To investigate the relationship between endothelial HGF and NOX4 in lung regeneration, we silenced Nox4 in injured mouse lungs (56). Nox4 shRNA was administered intratracheally into the pneumonectomized HgfiΔEC/iΔEC mice (fig. S5E). This method blocked the upregulation of NOX4 in perivascular fibroblasts, prevented fibrosis, and restored alveolar function in pneumonectomized HgfiΔEC/iΔEC lungs (fig. S5F–I). Of note, HGF blocked upregulation of NOX4 protein in cultured human and mouse lung fibroblasts after TGF-β treatment (Fig. 6E–F, fig. S6A–B), and incubating human lung fibroblasts with ECHGF abrogated NOX4 protein induction by TGF-β (Fig. 6G–H, fig. S6C). The degree of NOX4 upregulation in perivascular fibroblasts correlated with fibrosis grade in human fibrotic lung tissue samples (Fig. 6I), and perivascular NOX4 induction in HgfiΔEC/iΔEC mouse lungs after PNX recapitulated NOX4 expression in perivascular fibroblasts of human fibrotic lungs (Fig. 6J–L, fig. S6D–K). Therefore, endothelial HGF suppresses expression of NOX4 in perivascular lung fibroblasts, which may contribute to fibrogenesis in diseased human lungs.

Targeting dysfunctional vascular and perivascular cells enhances engraftment of AEC2s in fibrotic lungs

We investigated the therapeutic effect of Mec13-Hgf and GKT after repeated Bleo or Acid injections using mouse models. Jugular vein injection of Mec13-Hgf (15) in mice inhibited NOX4 upregulation in injured lung fibroblasts (Fig. 7A, B). Qualitative Sirius red staining implicated that Mec13-Hgf + GKT reduced fibrosis in the injured lungs (Fig. 7C). Moreover, Mec13-Hgf + GKT enhanced incorporation of AEC2s in damaged lungs, which stimulated lung regeneration more efficiently than any other treatments (Fig. 7D–F). These data suggest that editing dysfunctional vascular and perivascular cells can subvert an epithelially-prohibitive microenvironment to an epithelially-active niche, enabling regenerative therapy for fibrosis (fig. S7A).

Figure 7
Dual editing of vascular and perivascular niches facilitates incorporation of AEC2s, stimulating fibrosis-free lung repair

We also tested the efficacy of Mec13-Hgf + GKT on promoting reconstitution of human AEC2s. NCG mice were subjected to either Bleo or Acid injury and transplanted with GFP-labeled human AEC2s after Mec13-Srb, Mec13-Hgf, GKT, or Mec13-Hgf + GKT treatment (Fig. 8A). Mec13-Hgf + GKT efficiently promoted human AEC2 incorporation in the recipient mouse lungs (Fig. 8B). This engraftment was accompanied by blunted cell death, restored alveolar architecture, and recovered gas exchange function (Fig. 8C–E, fig. S7B).

Figure 8
Reconstitution of regenerative human AEC2s in the injured lungs following treatment with Mec13-Hgf and GKT

Discussion

The microenvironment of recipient organ, the “soil”, can regulate the efficiency of cell engraftment. Establishing an epithelially inductive microenvironment in diseased organs might facilitate the engraftment of regenerative parenchymal cells. In this study, we find that vascular and perivascular niche cells jointly regulate the incorporation of transplanted alveolar progenitor cell or hepatocyte in damaged organs. Parenchymal cell incorporation in injured lungs and livers requires expression of HGF in the endothelial niche and suppression of perivascular NOX4 activity. Moreover, incorporated parenchymal cells synergize with targeted niches to stimulate the most efficacious organ repair. Thus, reinstating self-repair capacity of diseased lung and liver might require the co-operation between the pro-regenerative microenvironment and grafted parenchymal stem/progenitor cells.

Fibrosis in injured organs might hamper engraftment of parenchymal cells. Therefore, understanding of how fibrosis is resolved during organ regeneration is helpful for devising cellular therapy for various diseases (1, 5). HGF has an important role in promoting parenchymal cell expansion (83, 9194). Here we found that EC-expressed HGF contributes to resolving lung and liver fibrosis, which is at least partially mediated by suppressing NOX4 expression in perivascular fibroblasts. In PH and PNX models that induce parenchymal regeneration without fibrosis, deletion of Hgf in mouse EC blocked regeneration and caused fibrosis. Reciprocally, in mouse liver and lung fibrosis models, ectopic expression of Hgf in EC prevented activation of perivascular fibroblast and suppressed fibrosis. These genetic model-based in vivo and in vitro cultivation data implicate that in addition to stimulating parenchymal reconstitution, endothelial HGF also serves as a key molecule to prevent fibrosis.

Therapeutically, NOX4 inhibition synergized with endothelial HGF induction to stimulate efficacious parenchymal reconstitution and regeneration. This synergistic effect may be due to several layers of mechanisms. First, reduced NOX4 in perivascular cells by endothelial HGF might require less NOX4 inhibitor to reach sufficient inhibition. Second, reducing oxidative stress in the damaged organs by NOX4 inhibitor may promote production or activation of HGF from the vascular niche. The additive effects by endothelial HGF and NOX4 inhibition might also rely on operative mechanisms independent of the HGF-NOX4 axis. Endothelial HGF can exert various regenerative functions (9194), and this dual editing approach might utilize both NOX4-dependent and NOX4-independnet mechanisms. NOX4 inhibition prevents parenchymal cell death after injury (95), offering hepatogenic or alveologenic effects that extend beyond HGF signaling. As such, our dual editing approach might exploit various functions of HGF and NOX4 that are independent of the HGF-NOX4 axis.

HGF expression triggered in the vascular niche after parenchymal injury may act as a protective response. The vast surface area of hepatic or pulmonary microvasculature is ideal to deploy enormous amounts of paracrine growth factors within a short time period (2, 75, 9698). Several endothelial receptors were demonstrated to mediate HGF upregulation in ECs, including VEGFR1 (48), VEGFR2 (80), and CXCR7 (16). Conceivably, these endothelial receptors sense tissue mass loss or chemical injury to trigger HGF expression. Loss of these pathways might not only impair regeneration but also cause fibrosis. It was shown before that activation of Smad2/3 blocks HGF transcription in keratinocytes (99). Whether the TGF/Smad pathway mediates the subversion of epithelially-inductive vascular niche function during parenchymal repair can be explored in the future.

The translational value of the dual niche-editing system could be improved through alternate gene transfer methods or coupling to different inhibitors or therapeutics. Pseudotyped lentivirus accomplishes EC-selective gene transfer at the expense of low efficiency; a therapeutically applicable EC gene editing approach might require a clinically tested gene transfer system with higher efficiency. Engineered Adeno-associated virus (AAV) can be chemically conjugated with an endothelial targeting moiety via process such as biotin-avidin interaction (87, 89). Administration of EC-targeted AAV can potentially offer more efficacious and safer vascular gene editing in fibrotic organs. Other therapeutics can be exploited to target the dysfunctional perivascular niche in conjugation with NOX4 inhibitor.

Taken together, we show that vascular and perivascular cells jointly influence the engraftment of parenchymal progenitor cells in the inured lungs and livers. Implementing cell transplantation with niche editing efficiently induces organ regeneration. Our proof-of-principle evidence may help develop cell therapy approaches to enable fibrosis-free repair in various organs.

Materials and Methods

Study Design

We combined vascular Hgf gene expression with NOX4 inhibition via GKT137831 to edit the vascular and perivascular niches in fibrotic lung and liver. The contribution of vascular and perivascular niches were demonstrated by suppressed parenchymal cell engraftment in host mice lacking endothelial HGF and overexpressing perivascular NOX4. The role of endothelial HGF in promoting parenchymal regeneration and bypassing fibrosis in liver and lung was established using 1) EC-specific knockout (HgfiΔEC/iΔEC) mice and 2) complementary lung and liver regeneration and repair models. Both AEC2s and hepatocytes were grafted into recipient mice after treatment with EC-targeted Hgf, GKT137831, or combination therapy. We analyzed the extent of incorporation of transplanted mouse and human parenchymal cells in the recipient mice, and tested the efficacy of functional organ repair in liver and lung injury models. Investigators who performed mouse experiments and who analyzed the pattern and extent of cell distribution and tissue pathology were randomly assigned with animal or human samples. Investigators were blinded to the phenotypes of samples from different groups. For quantitative experiments consisting of n < 20 animals per group, individual level data are shown in table S1.

Genetic mouse models

The AEC2-specific Sftpc-CreERT2 mouse line was kindly provided by Dr. Brigid Hogan at Duke University, and hepatocyte-specific Albumin-Cre mouse and ROSA26-TdTomato reporter mouse expressing TdTomato after floxed stop codon were purchased from the Jackson Laboratories. Sftpc-CreERT2 and Albumin-Cre mice were bred with ROSA26-TdTomato mice, and Sftpc-CreERT2 expression in the offspring mouse was induced by 6 consecutive intraperitoneal injections of 100 mg/kg tamoxifen (Sigma-Aldrich). Expression of Cre induced excision of the stop codon preceding TdTomato and triggered expression of red fluorescent protein in AEC2s and hepatocytes. Floxed Hgf mice were obtained from mutant mouse regional resource centers (No 000423). Mice expressing EC-specific Cdh5-(PAC)-CreERT2 (84) were provided by Dr. Ralf Adams. This mouse line was crossed with floxed Hgf mice to generate HgfiΔEC/iΔEC mice and control HgfiΔEC/+ mice after treatment of tamoxifen at a dose of 150 mg/kg for 6 days, and interrupted for 3 days after the third dose. Deletion of target genes in ECs was corroborated by quantitative polymerase chain reaction (PCR). Six to ten weeks old sex and weight matched HgfiΔEC/iΔEC and HgfiΔEC/+ mice and male WT mice were used for mouse PH, PNX and liver and lung injury models. Six to ten weeks old immunodeficient NCG mice from Nanjing Biomedical Research Institute of Nanjing University were used for transplantation of human hepatocytes and AEC2s. All animal experiments were carried out by protocols approved by the Institutional Animal Care and Use Committee at Sichuan University and Weill Cornell Medicine.

Liver and lung injury models

Injections of CCl4 were used to induce liver injury as previously described (16). CCl4 was diluted in olive oil (Sigma-Aldrich) to yield a concentration of 40% (0.64 mg/ml) and intraperitoneally injected to mice at a dose of 1.6 g/kg. Mice were subjected to BDL to induce cirrhotic liver injury (16). To perform BDL, mice were anesthetized with a cocktail of ketamine (100 mg/kg) and xylazine (10 mg/kg). Ketamine and xylazine were provided by approved veterinary service at Weill Cornell Medicine. Repetitive intratracheal bleomycin or hydrochloric acid injection models were used to induce lung injury (100). At the described time points, oxygen tension in arterial blood of treated mice was measured using I-Stat (Abbott Laboratories).

Transplantation of mouse and human parenchymal cells

AEC2s and hepatocytes expressing TdTomato were isolated as described (21, 51, 80). To isolate AEC2s, the mouse lungs were removed and digested in cocktail solution containing 2 mg/ml collagenase A and 1 mg/ml Dispase (Roche Life Science) in Hanks’ Balanced Salted Solution (HBSS). 1 ml digestion solution was directly instilled via the trachea and used to perfuse via pulmonary artery to accelerate the digestion process. Perfused mouse lungs were removed from the chest cavity to endothelial cell growth medium (Sigma-Aldrich), minced, and disrupted. Lungs were then suspended in 2.5 ml/100mg digestion cocktail at 37 °C for 15 min. Digested lungs were filtered through a 40 μm nylon mesh (cell strainer) and centrifuged. Cell suspension was centrifuged via Percoll gradient. AEC2 band was harvested, and TdTomato+ AEC2s were sorted by flow cytometry. Human AEC2s were purchased from iCell Bioscience Inc.

For mouse AEC2 transplantation, 3 million isolated mouse AEC2s were infused into mouse lungs via trachea 3 days after the 3rd or 6th Bleo or Acid treatment. Mice were also treated with Mec13-Srb, Mec13-Hgf, GKT, or Mec13-Hgf + GKT after the 3rd Bleo or Acid, and 3 million of mouse AEC2s were transplanted after 5th Bleo or 6th Acid. For human AEC2 transplantation, ten million human AEC2s were labeled with GFP and transplanted into immunodeficient NCG mice after indicated treatments. Recipient mice were sacrificed ten days after transplantation to determine the incorporation of transplanted cells in the injured lungs. Blood oxygen tension was analyzed 20 days after last Bleo or Acid injury.

Hepatocytes were purified as described via a two-step perfusion and digestion procedure (51, 80). Human hepatocytes were obtained from BioreclamationIVT. For mouse hepatocyte transplantation, 2.5 million isolated mouse hepatocytes were transplanted to the injured mouse liver via intrasplenic injection (80) three days after the 3rd or 8th injection of CCl4. Intrasplenic injection was also performed as described (80). Ten million human hepatocytes were transplanted into NCG mice at day 10 after BDL injury. Recipient mice were sacrificed at day 21 after BDL to assess the extent of hepatocyte incorporation in the injured liver.

Mouse liver and lung injury models

A mouse PH model was used to induce liver regeneration (80). Left lung PNX model and measurement of alveolar regeneration (79, 98) and lung injury (15) were adapted. Animal experiment procedures are described in supplementary methods. Liver and lung fibrotic responses were determined at the indicated time after injection of Bleo, Acid, CCl4, or BDL. Collagen distribution was assessed by Sirius red staining (15). Hydroxyproline amount was quantified in the liver and lung to determine the extent of fibrosis (15, 55). To measure peroxide formation in the tissue, immunostaining and ELISA of MDA were performed using antibody against MDA (Abcam) and a lipid peroxidation assay kit (Abcam). Generation of H2O2 in cultured stellate cells and lung fibroblasts were performed as described (76).

Culture of hepatic stellate cell and lung fibroblast

For co-culture experiments with human ECs, 200 ul matrigel (BD Biosciences) was incubated in 24 well plate, and fluorescently labeled human stellate cell LX-2 or lung fibroblasts and mCherry-labeled ECs were seeded at 1 to 1 ratio on matrigel (BD biosciences). Formation of 3 dimensional vascular tubes was imaged by fluorescent microscope. Human stellate cell line LX-2 was generously provided by Dr. Scott Friedman (Mount Sinai Hospital), and mouse hepatic stellate cell was obtained from ScienceCell Research Laboratories. Human and mouse lung fibroblasts were purchased from Science Cell Inc. Human ECs were obtained from Angiocrine Bioscience. Cultured stellate and fibroblast cells were treated with 20 ng/ml recombinant TGF-β and 40 ng/ml HGF (PeproTech Inc.) and retrieved for NOX4 protein analysis by Western blot.

NOX4 inhibitor GKT137831 and EC-specific delivery of Hgf

Pseudotyped lentiviral particles containing Hgf were conjugated with Mec13.3 antibody to induce HGF expression in endothelial cell (Mec13-Hgf). Lentivirus containing Srb construct was similarly processed with Mec13.3 as a control group (Mec13-Srb). After the third Bleo, Acid injection or BDL, six to eight weeks old mice were subjected to Mec13-Hgf or Mec13-Srb every three days at a dose of 75 μg p24 capsid protein. The effect of GKT137831 was tested in lung and liver fibrosis models. GKT137831 was dissolved in an aqueous solution (0.5% carboxymethylcellulose and 0.25% Tween 20). 10 mg/kg GKT137831 was given to mice twice weekly by oral gavage (started together with Mec13-Hgf) (56, 76). The effect of combination treatment was compared with vehicle, Mec13-Hgf, or GKT137831 alone.

Immunostaining and histological analysis of mouse and human cryosections

Mouse liver and lung tissues were harvested for histological analysis (16, 80). Human sample sources are described in supplementary material. For immunofluorescent microscopy, the liver sections (10 μm) were blocked (5% donkey serum/0.3% Triton X-100) and incubated in primary antibodies: anti-VE-cadherin polyclonal antibody (pAb, 2 μg/ml, R&D Systems), anti-NOX4 (pAb, 5 μg/ml, Abcam), anti-MDA antibody (5 μg/ml, Ab6463, Abcam), and anti-desmin (pAb, 2 μg/ml, Abcam). After incubation in fluorophore-conjugated secondary antibodies (2.5 μg/ml, Jackson ImmunoResearch), sections were counterstained with DAPI (Invitrogen). For each animal, five sections were analyzed for each animal.

Image acquisition and analysis

Histology analysis and Sirius red staining of liver or lung sections were captured with Olympus BX51 microscope (Olympus America, NY). Densitometry analysis of Western blot image was performed with ImageJ software using calibrated standard curve of optical density, and fluorescent images were recorded on AxioVert LSM710 confocal microscope (Zeiss).

Statistical analysis

All data were presented as the mean ± standard error of mean (S.E.M). For statistical analysis of experiments where there are more than two treated groups, one-way analysis of variance (ANOVA) was performed, followed by Tukey’s test as post hoc analysis. Comparison of statistical difference between two experimental groups was determined by two tailed t-test.

Supplementary Material

Supplementary Materials

Fig. S1. Characterization of parenchymal cell incorporation in the mouse lungs and livers.

Fig. S2. EC-expressed HGF is required for bypassing fibrosis and stimulating regeneration after liver and lung injury.

Fig. S3. Expression of NOX4 in liver fibroblasts.

Fig. S4. Dual editing of vascular and perivascular niches promotes liver repair.

Fig. S5. EC-expressed HGF suppresses perivascular NOX4 expression to stimulate lung alveolar regeneration and attenuate fibrosis.

Fig. S6. Expression of NOX4 in lung fibroblasts.

Fig. S7. Dual editing of vascular and perivascular cells blocks fibrosis and facilitates lung repair.

Table S1. Individual level data.

Acknowledgments

We are grateful to Dr. Scott L. Friedman (Mount Sinai Hospital, NY) for kindly providing human hepatic stellate cell LX-2. We want to thank Dr. Irvin S.Y. Chen (UCLA, CA) for offering pseudotype virus vector. We are indebted to Dr. Ralf H. Adams (Max Planck Institute, Germany) and Dr. Brigid L.M. Hogan (Duke University, NC) for EC-specific Cdh5-(PAC)-CreERT2 mice and AEC2-specific Sftpc-CreERT2 mouse line.

Funding: This work was supported by National Scientist Development Grant from the American Heart Association (12SDG1213004), National Heart, Lung, and Blood Institute (R01HL097797, R01HL119872, R01HL130826), National Natural Science Foundation of China (91639117), and National Key Research and Development Program focused on Stem Cell and Translational Research (2016YFA0101600). S.R. is also supported by the Empire State Stem Cell Board and New York State Department of Health grants (C024180, C026438, C026878, C028117).

Footnotes

Author Contributions: Z.C. conceived the project, performed the experiments, analyzed the results, and wrote the paper. T.Y., Y.S. G.J. designed and carried out the experiments, analyzed the data and edited the manuscript. K.S, Y.C, L.L, F.N., X.L., and Z.H. performed the experiments. J.L.K, V.M., L.Q., and C.C. analyzed the data. F.J.M commented on the study, and edited the manuscript. S.R. commented on the study. B.-S.D. designed and carried out the experiments, interpreted the results, and wrote the manuscript.

Competing interests: The authors have declared that no conflict of interest exists.

Data and materials availability: All materials are contained within manuscript and supplementary materials.

References

1. Friedman SL, Sheppard D, Duffield JS, Violette S. Therapy for fibrotic diseases: nearing the starting line. Science translational medicine. 2013;5:167sr161. doi: 10.1126/scitranslmed.3004700. published online EpubJan 9. [PubMed] [Cross Ref]
2. Hu J, Srivastava K, Wieland M, Runge A, Mogler C, Besemfelder E, Terhardt D, Vogel MJ, Cao L, Korn C, Bartels S, Thomas M, Augustin HG. Endothelial cell-derived angiopoietin-2 controls liver regeneration as a spatiotemporal rheostat. Science. 2014;343:416–419. published online EpubJan 24. [PubMed]
3. Kotton DN, Morrisey EE. Lung regeneration: mechanisms, applications and emerging stem cell populations. Nature medicine. 2014;20:822–832. doi: 10.1038/nm.3642. published online EpubAug. [PMC free article] [PubMed] [Cross Ref]
4. Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nature medicine. 2012;18:1028–1040. published online EpubJul. [PMC free article] [PubMed]
5. Thannickal VJ, Zhou Y, Gaggar A, Duncan SR. Fibrosis: ultimate and proximate causes. The Journal of clinical investigation. 2014;124:4673–4677. doi: 10.1172/JCI74368. published online EpubNov. [PMC free article] [PubMed] [Cross Ref]
6. N. Idiopathic Pulmonary Fibrosis Clinical Research. Raghu G, Anstrom KJ, King TE, Jr, Lasky JA, Martinez FJ. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. The New England journal of medicine. 2012;366:1968–1977. doi: 10.1056/NEJMoa1113354. published online EpubMay 24. [PMC free article] [PubMed] [Cross Ref]
7. Hogan BL, Barkauskas CE, Chapman HA, Epstein JA, Jain R, Hsia CC, Niklason L, Calle E, Le A, Randell SH, Rock J, Snitow M, Krummel M, Stripp BR, Vu T, White ES, Whitsett JA, Morrisey EE. Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function. Cell stem cell. 2014;15:123–138. doi: 10.1016/j.stem.2014.07.012. published online EpubAug 07. [PMC free article] [PubMed] [Cross Ref]
8. Mehal WZ, Iredale J, Friedman SL. Scraping fibrosis: expressway to the core of fibrosis. Nature medicine. 2011;17:552–553. published online EpubMay. [PMC free article] [PubMed]
9. Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Science translational medicine. 2014;6:265sr266. doi: 10.1126/scitranslmed.3009337. published online EpubDec 3. [PMC free article] [PubMed] [Cross Ref]
10. Loeys BL, Gerber EE, Riegert-Johnson D, Iqbal S, Whiteman P, McConnell V, Chillakuri CR, Macaya D, Coucke PJ, De Paepe A, Judge DP, Wigley F, Davis EC, Mardon HJ, Handford P, Keene DR, Sakai LY, Dietz HC. Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome. Science translational medicine. 2010;2:23ra20. doi: 10.1126/scitranslmed.3000488. published online EpubMar 17. [PMC free article] [PubMed] [Cross Ref]
11. Reed NI, Jo H, Chen C, Tsujino K, Arnold TD, DeGrado WF, Sheppard D. The alphavbeta1 integrin plays a critical in vivo role in tissue fibrosis. Science translational medicine. 2015;7:288ra279. doi: 10.1126/scitranslmed.aaa5094. published online EpubMay 20. [PMC free article] [PubMed] [Cross Ref]
12. Bataller R, Brenner DA. Liver fibrosis. The Journal of clinical investigation. 2005;115:209–218. published online EpubFeb. [PMC free article] [PubMed]
13. Xu Y, Mizuno T, Sridharan A, Du Y, Guo M, Tang J, Wikenheiser-Brokamp KA, Perl AT, Funari VA, Gokey JJ, Stripp BR, Whitsett JA. Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis. JCI insight. 2016;1:e90558. doi: 10.1172/jci.insight.90558. published online EpubDec 08. [PMC free article] [PubMed] [Cross Ref]
14. Rock JR, Barkauskas CE, Cronce MJ, Xue Y, Harris JR, Liang J, Noble PW, Hogan BL. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proceedings of the National Academy of Sciences of the United States of America. 2011;108:E1475–1483. published online EpubDec 27. [PubMed]
15. Cao Z, Lis R, Ginsberg M, Chavez D, Shido K, Rabbany SY, Fong GH, Sakmar TP, Rafii S, Ding BS. Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates fibrosis. Nature medicine. 2016;22:154–162. doi: 10.1038/nm.4035. published online EpubFeb. [PMC free article] [PubMed] [Cross Ref]
16. Ding BS, Cao Z, Lis R, Nolan DJ, Guo P, Simons M, Penfold ME, Shido K, Rabbany SY, Rafii S. Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis. Nature. 2014;505:97–102. doi: 10.1038/nature12681. published online EpubJan 2. [PMC free article] [PubMed] [Cross Ref]
17. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453:314–321. published online EpubMay 15. [PubMed]
18. Zhao J, Zhang Z, Luan Y, Zou Z, Sun Y, Li Y, Jin L, Zhou C, Fu J, Gao B, Fu Y, Wang FS. Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment. Hepatology (Baltimore, Md. 2014;59:1331–1342. doi: 10.1002/hep.26916. published online EpubApr. [PMC free article] [PubMed] [Cross Ref]
19. Manavski Y, Abel T, Hu J, Kleinlutzum D, Buchholz CJ, Belz C, Augustin HG, Boon RA, Dimmeler S. Endothelial transcription factor KLF2 negatively regulates liver regeneration via induction of activin A. Proceedings of the National Academy of Sciences of the United States of America. 2017;114:3993–3998. doi: 10.1073/pnas.1613392114. published online EpubApr 11. [PubMed] [Cross Ref]
20. Vaughan AE, Brumwell AN, Xi Y, Gotts JE, Brownfield DG, Treutlein B, Tan K, Tan V, Liu FC, Looney MR, Matthay MA, Rock JR, Chapman HA. Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury. Nature. 2015;517:621–625. doi: 10.1038/nature14112. published online EpubJan 29. [PMC free article] [PubMed] [Cross Ref]
21. Desai TJ, Brownfield DG, Krasnow MA. Alveolar progenitor and stem cells in lung development, renewal and cancer. Nature. 2014 published online EpubFeb 5. [PMC free article] [PubMed]
22. Zuo W, Zhang T, Wu DZ, Guan SP, Liew AA, Yamamoto Y, Wang X, Lim SJ, Vincent M, Lessard M, Crum CP, Xian W, McKeon F. p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration. Nature. 2015;517:616–620. doi: 10.1038/nature13903. published online EpubJan 29. [PubMed] [Cross Ref]
23. Tata PR, Mou H, Pardo-Saganta A, Zhao R, Prabhu M, Law BM, Vinarsky V, Cho JL, Breton S, Sahay A, Medoff BD, Rajagopal J. Dedifferentiation of committed epithelial cells into stem cells in vivo. Nature. 2013;503:218–223. published online EpubNov 14. [PMC free article] [PubMed]
24. Liang J, Zhang Y, Xie T, Liu N, Chen H, Geng Y, Kurkciyan A, Mena JM, Stripp BR, Jiang D, Noble PW. Hyaluronan and TLR4 promote surfactant-protein-C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice. Nature medicine. 2016;22:1285–1293. doi: 10.1038/nm.4192. published online EpubNov. [PMC free article] [PubMed] [Cross Ref]
25. Huang SX, Islam MN, O’Neill J, Hu Z, Yang YG, Chen YW, Mumau M, Green MD, Vunjak-Novakovic G, Bhattacharya J, Snoeck HW. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nature biotechnology. 2014;32:84–91. doi: 10.1038/nbt.2754. published online EpubJan. [PMC free article] [PubMed] [Cross Ref]
26. Barkauskas CE, Cronce MJ, Rackley CR, Bowie EJ, Keene DR, Stripp BR, Randell SH, Noble PW, Hogan BL. Type 2 alveolar cells are stem cells in adult lung. The Journal of clinical investigation. 2013;123:3025–3036. doi: 10.1172/JCI6878268782. published online EpubJul 1. [pii] [PMC free article] [PubMed] [Cross Ref]
27. Zaret KS, Grompe M. Generation and regeneration of cells of the liver and pancreas. Science. 2008;322:1490–1494. published online EpubDec 5. [PMC free article] [PubMed]
28. Soto-Gutierrez A, Kobayashi N, Rivas-Carrillo JD, Navarro-Alvarez N, Zhao D, Okitsu T, Noguchi H, Basma H, Tabata Y, Chen Y, Tanaka K, Narushima M, Miki A, Ueda T, Jun HS, Yoon JW, Lebkowski J, Tanaka N, Fox IJ. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nature biotechnology. 2006;24:1412–1419. published online EpubNov. [PubMed]
29. Duncan AW, Taylor MH, Hickey RD, Hanlon Newell AE, Lenzi ML, Olson SB, Finegold MJ, Grompe M. The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature. 2010;467:707–710. published online EpubOct 7. [PMC free article] [PubMed]
30. Wang B, Zhao L, Fish M, Logan CY, Nusse R. Self-renewing diploid Axin2(+) cells fuel homeostatic renewal of the liver. Nature. 2015;524:180–185. doi: 10.1038/nature14863. published online EpubAug 13. [PMC free article] [PubMed] [Cross Ref]
31. Wangensteen KJ, Zhang S, Greenbaum LE, Kaestner KH. A genetic screen reveals Foxa3 and TNFR1 as key regulators of liver repopulation. Genes & development. 2015;29:904–909. doi: 10.1101/gad.258855.115. published online EpubMay 1. [PubMed] [Cross Ref]
32. Rosen C, Shezen E, Aronovich A, Klionsky YZ, Yaakov Y, Assayag M, Biton IE, Tal O, Shakhar G, Ben-Hur H, Shneider D, Vaknin Z, Sadan O, Evron S, Freud E, Shoseyov D, Wilschanski M, Berkman N, Fibbe WE, Hagin D, Hillel-Karniel C, Krentsis IM, Bachar-Lustig E, Reisner Y. Preconditioning allows engraftment of mouse and human embryonic lung cells, enabling lung repair in mice. Nature medicine. 2015;21:869–879. doi: 10.1038/nm.3889. published online EpubAug. [PubMed] [Cross Ref]
33. Yanger K, Knigin D, Zong Y, Maggs L, Gu G, Akiyama H, Pikarsky E, Stanger BZ. Adult hepatocytes are generated by self-duplication rather than stem cell differentiation. Cell stem cell. 2014;15:340–349. doi: 10.1016/j.stem.2014.06.003. published online EpubSep 4. [PMC free article] [PubMed] [Cross Ref]
34. Zhu S, Rezvani M, Harbell J, Mattis AN, Wolfe AR, Benet LZ, Willenbring H, Ding S. Mouse liver repopulation with hepatocytes generated from human fibroblasts. Nature. 2014;508:93–97. doi: 10.1038/nature13020. published online EpubApr 03. [PMC free article] [PubMed] [Cross Ref]
35. Fan F, He Z, Kong LL, Chen Q, Yuan Q, Zhang S, Ye J, Liu H, Sun X, Geng J, Yuan L, Hong L, Xiao C, Zhang W, Sun X, Li Y, Wang P, Huang L, Wu X, Ji Z, Wu Q, Xia NS, Gray NS, Chen L, Yun CH, Deng X, Zhou D. Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration. Science translational medicine. 2016;8:352ra108. doi: 10.1126/scitranslmed.aaf2304. published online EpubAug 17. [PubMed] [Cross Ref]
36. Huang P, He Z, Ji S, Sun H, Xiang D, Liu C, Hu Y, Wang X, Hui L. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature. 2011;475:386–389. doi: 10.1038/nature10116. published online EpubMay 11. [PubMed] [Cross Ref]
37. Sekiya S, Suzuki A. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature. 2011;475:390–393. doi: 10.1038/nature10263. published online EpubJun 29. [PubMed] [Cross Ref]
38. Li X, Liu D, Ma Y, Du X, Jing J, Wang L, Xie B, Sun D, Sun S, Jin X, Zhang X, Zhao T, Guan J, Yi Z, Lai W, Zheng P, Huang Z, Chang Y, Chai Z, Xu J, Deng H. Direct Reprogramming of Fibroblasts via a Chemically Induced XEN-like State. Cell stem cell. 2017 doi: 10.1016/j.stem.2017.05.019. published online EpubJun 20. [PubMed] [Cross Ref]
39. Kordes C, Haussinger D. Hepatic stem cell niches. The Journal of clinical investigation. 2013;123:1874–1880. doi: 10.1172/JCI66027. published online EpubMay. [PMC free article] [PubMed] [Cross Ref]
40. Pardo-Saganta A, Tata PR, Law BM, Saez B, Chow R, Prabhu M, Gridley T, Rajagopal J. Parent stem cells can serve as niches for their daughter cells. Nature. 2015;523:597–601. doi: 10.1038/nature14553. published online EpubJul 30. [PMC free article] [PubMed] [Cross Ref]
41. Hidalgo A, Chang J, Jang JE, Peired AJ, Chiang EY, Frenette PS. Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nature medicine. 2009;15:384–391. published online EpubApr. [PMC free article] [PubMed]
42. Boulter L, Govaere O, Bird TG, Radulescu S, Ramachandran P, Pellicoro A, Ridgway RA, Seo SS, Spee B, Van Rooijen N, Sansom OJ, Iredale JP, Lowell S, Roskams T, Forbes SJ. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nature medicine. 2012;18:572–579. doi: 10.1038/nm.2667. published online EpubApr. [PMC free article] [PubMed] [Cross Ref]
43. Branchfield K, Nantie L, Verheyden JM, Sui P, Wienhold MD, Sun X. Pulmonary neuroendocrine cells function as airway sensors to control lung immune response. Science. 2016;351:707–710. doi: 10.1126/science.aad7969. published online EpubFeb 12. [PMC free article] [PubMed] [Cross Ref]
44. Peng T, Frank DB, Kadzik RS, Morley MP, Rathi KS, Wang T, Zhou S, Cheng L, Lu MM, Morrisey EE. Hedgehog actively maintains adult lung quiescence and regulates repair and regeneration. Nature. 2015;526:578–582. doi: 10.1038/nature14984. published online EpubOct 22. [PMC free article] [PubMed] [Cross Ref]
45. Lechner AJ, Driver IH, Lee J, Conroy CM, Nagle A, Locksley RM, Rock JR. Recruited Monocytes and Type 2 Immunity Promote Lung Regeneration following Pneumonectomy. Cell stem cell. 2017 doi: 10.1016/j.stem.2017.03.024. published online EpubMay 11. [PubMed] [Cross Ref]
46. Paris AJ, Liu Y, Mei J, Dai N, Guo L, Spruce LA, Hudock KM, Brenner JS, Zacharias WJ, Mei HD, Slamowitz AR, Bhamidipati K, Beers MF, Seeholzer SH, Morrisey EE, Worthen GS. Neutrophils promote alveolar epithelial regeneration by enhancing type II pneumocyte proliferation in a model of acid-induced acute lung injury. American journal of physiology Lung cellular and molecular physiology. 2016;311:L1062–L1075. doi: 10.1152/ajplung.00327.2016. published online EpubDec 01. [PubMed] [Cross Ref]
47. Lefrancais E, Ortiz-Munoz G, Caudrillier A, Mallavia B, Liu F, Sayah DM, Thornton EE, Headley MB, David T, Coughlin SR, Krummel MF, Leavitt AD, Passegue E, Looney MR. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature. 2017;544:105–109. doi: 10.1038/nature21706. published online EpubApr 06. [PubMed] [Cross Ref]
48. LeCouter J, Moritz DR, Li B, Phillips GL, Liang XH, Gerber HP, Hillan KJ, Ferrara N. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science. 2003;299:890–893. published online EpubFeb 7. [PubMed]
49. Matsumoto K, Yoshitomi H, Rossant J, Zaret KS. Liver organogenesis promoted by endothelial cells prior to vascular function. Science. 2001;294:559–563. published online EpubOct 19. [PubMed]
50. Michalopoulos GK, DeFrances MC. Liver regeneration. Science. 1997;276:60–66. published online EpubApr 4. [PubMed]
51. Wei K, Piecewicz SM, McGinnis LM, Taniguchi CM, Wiegand SJ, Anderson K, Chan CW, Mulligan KX, Kuo D, Yuan J, Vallon M, Morton LC, Lefai E, Simon MC, Maher JJ, Mithieux G, Rajas F, Annes JP, McGuinness OP, Thurston G, Giaccia AJ, Kuo CJ. A liver Hif-2alpha-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition. Nature medicine. 2013;19:1331–1337. doi: 10.1038/nm.3295. published online EpubOct. [PMC free article] [PubMed] [Cross Ref]
52. Wang L, Wang X, Xie G, Wang L, Hill CK, Deleve LD. Liver sinusoidal endothelial cell progenitor cells promote liver regeneration in rats. The Journal of clinical investigation. 2012;122:1567–1573. published online EpubApr 2. [PMC free article] [PubMed]
53. Islam MN, Das SR, Emin MT, Wei M, Sun L, Westphalen K, Rowlands DJ, Quadri SK, Bhattacharya S, Bhattacharya J. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nature medicine. 2012;18:759–765. published online EpubMay. [PMC free article] [PubMed]
54. Beers MF, Morrisey EE. The three R’s of lung health and disease: repair, remodeling, and regeneration. The Journal of clinical investigation. 2011;121:2065–2073. published online EpubJun 1. [PMC free article] [PubMed]
55. Ding BS, Liu CH, Sun Y, Chen Y, Swendeman SL, Jung B, Chavez D, Cao Z, Christoffersen C, Nielsen LB, Schwab SR, Rafii S, Hla T. HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver. JCI insight. 2016;1:e87058. doi: 10.1172/jci.insight.87058. published online EpubDec 22. [PMC free article] [PubMed] [Cross Ref]
56. Hecker L, Vittal R, Jones T, Jagirdar R, Luckhardt TR, Horowitz JC, Pennathur S, Martinez FJ, Thannickal VJ. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nature medicine. 2009;15:1077–1081. published online EpubSep. [PMC free article] [PubMed]
57. Henderson NC, Arnold TD, Katamura Y, Giacomini MM, Rodriguez JD, McCarty JH, Pellicoro A, Raschperger E, Betsholtz C, Ruminski PG, Griggs DW, Prinsen MJ, Maher JJ, Iredale JP, Lacy-Hulbert A, Adams RH, Sheppard D. Targeting of alphav integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nature medicine. 2013;19:1617–1624. published online EpubDec. [PMC free article] [PubMed]
58. Noble PW, Barkauskas CE, Jiang D. Pulmonary fibrosis: patterns and perpetrators. The Journal of clinical investigation. 2012;122:2756–2762. published online EpubAug 1. [PMC free article] [PubMed]
59. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nature medicine. 2007;13:1324–1332. published online EpubNov. [PubMed]
60. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nature medicine. 2007;13:952–961. published online EpubAug. [PubMed]
61. Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nature reviews. 2014;14:181–194. doi: 10.1038/nri3623. published online EpubMar. [PubMed] [Cross Ref]
62. Herazo-Maya JD, Noth I, Duncan SR, Kim S, Ma SF, Tseng GC, Feingold E, Juan-Guardela BM, Richards TJ, Lussier Y, Huang Y, Vij R, Lindell KO, Xue J, Gibson KF, Shapiro SD, Garcia JG, Kaminski N. Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis. Science translational medicine. 2013;5:205ra136. doi: 10.1126/scitranslmed.3005964. published online EpubOct 2. [PMC free article] [PubMed] [Cross Ref]
63. Zhou Y, Peng H, Sun H, Peng X, Tang C, Gan Y, Chen X, Mathur A, Hu B, Slade MD, Montgomery RR, Shaw AC, Homer RJ, White ES, Lee CM, Moore MW, Gulati M, Lee CG, Elias JA, Herzog EL. Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in Mammalian lung fibrosis. Science translational medicine. 2014;6:240ra276. doi: 10.1126/scitranslmed.3007096. published online EpubJun 11. [PMC free article] [PubMed] [Cross Ref]
64. Ramachandran P, Iredale JP. Macrophages: central regulators of hepatic fibrogenesis and fibrosis resolution. Journal of hepatology. 2012;56:1417–1419. doi: 10.1016/j.jhep.2011.10.026. published online EpubJun. [PubMed] [Cross Ref]
65. Coon TA, McKelvey AC, Lear T, Rajbhandari S, Dunn SR, Connelly W, Zhao JY, Han S, Liu Y, Weathington NM, McVerry BJ, Zhang Y, Chen BB. The proinflammatory role of HECTD2 in innate immunity and experimental lung injury. Science translational medicine. 2015;7:295ra109. doi: 10.1126/scitranslmed.aab3881. published online EpubJul 8. [PMC free article] [PubMed] [Cross Ref]
66. Zou C, Li J, Xiong S, Chen Y, Wu Q, Li X, Weathington NM, Han S, Snavely C, Chen BB, Mallampalli RK. Mortality factor 4 like 1 protein mediates epithelial cell death in a mouse model of pneumonia. Science translational medicine. 2015;7:311ra171. doi: 10.1126/scitranslmed.aac7793. published online EpubOct 28. [PMC free article] [PubMed] [Cross Ref]
67. Tager AM, LaCamera P, Shea BS, Campanella GS, Selman M, Zhao Z, Polosukhin V, Wain J, Karimi-Shah BA, Kim ND, Hart WK, Pardo A, Blackwell TS, Xu Y, Chun J, Luster AD. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nature medicine. 2008;14:45–54. doi: 10.1038/nm1685. published online EpubJan. [PubMed] [Cross Ref]
68. El Agha E, Moiseenko A, Kheirollahi V, De Langhe S, Crnkovic S, Kwapiszewska G, Kosanovic D, Schwind F, Schermuly RT, Henneke I, MacKenzie B, Quantius J, Herold S, Ntokou A, Ahlbrecht K, Morty RE, Gunther A, Seeger W, Bellusci S. Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis. Cell stem cell. 2017;20:261–273 e263. doi: 10.1016/j.stem.2016.10.004. published online EpubFeb 02. [PubMed] [Cross Ref]
69. Yin C, Evason KJ, Asahina K, Stainier DY. Hepatic stellate cells in liver development, regeneration, and cancer. The Journal of clinical investigation. 2013;123:1902–1910. doi: 10.1172/JCI66369. published online EpubMay. [PMC free article] [PubMed] [Cross Ref]
70. Lee JH, Bhang DH, Beede A, Huang TL, Stripp BR, Bloch KD, Wagers AJ, Tseng YH, Ryeom S, Kim CF. Lung Stem Cell Differentiation in Mice Directed by Endothelial Cells via a BMP4-NFATc1-Thrombospondin-1 Axis. Cell. 2014;156:440–455. published online EpubJan 30. [PMC free article] [PubMed]
71. Petrache I, Natarajan V, Zhen L, Medler TR, Richter AT, Cho C, Hubbard WC, Berdyshev EV, Tuder RM. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nature medicine. 2005;11:491–498. published online EpubMay. [PMC free article] [PubMed]
72. Cai Y, Bolte C, Le T, Goda C, Xu Y, Kalin TV, Kalinichenko VV. FOXF1 maintains endothelial barrier function and prevents edema after lung injury. Science signaling. 2016;9:ra40. doi: 10.1126/scisignal.aad1899. published online EpubApr 19. [PubMed] [Cross Ref]
73. Mirza MK, Sun Y, Zhao YD, Potula HH, Frey RS, Vogel SM, Malik AB, Zhao YY. FoxM1 regulates re-annealing of endothelial adherens junctions through transcriptional control of beta-catenin expression. The Journal of experimental medicine. 2010;207:1675–1685. doi: 10.1084/jem.20091857. published online EpubAug 02. [PMC free article] [PubMed] [Cross Ref]
74. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473:298–307. published online EpubMay 19. [PMC free article] [PubMed]
75. Rafii S, Butler JM, Ding BS. Angiocrine functions of organ-specific endothelial cells. Nature. 2016;529:316–325. doi: 10.1038/nature17040. published online EpubJan 21. [PMC free article] [PubMed] [Cross Ref]
76. Hecker L, Logsdon NJ, Kurundkar D, Kurundkar A, Bernard K, Hock T, Meldrum E, Sanders YY, Thannickal VJ. Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Science translational medicine. 2014;6:231ra247. doi: 10.1126/scitranslmed.3008182. published online EpubApr 09. [PMC free article] [PubMed] [Cross Ref]
77. Moon JS, Nakahira K, Chung KP, DeNicola GM, Koo MJ, Pabon MA, Rooney KT, Yoon JH, Ryter SW, Stout-Delgado H, Choi AM. NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages. Nature medicine. 2016;22:1002–1012. doi: 10.1038/nm.4153. published online EpubSep. [PMC free article] [PubMed] [Cross Ref]
78. Nishikawa T, Bell A, Brooks JM, Setoyama K, Melis M, Han B, Fukumitsu K, Handa K, Tian J, Kaestner KH, Vodovotz Y, Locker J, Soto-Gutierrez A, Fox IJ. Resetting the transcription factor network reverses terminal chronic hepatic failure. The Journal of clinical investigation. 2015;125:1533–1544. published online EpubApr. [PMC free article] [PubMed]
79. Ding BS, Nolan DJ, Guo P, Babazadeh AO, Cao Z, Rosenwaks Z, Crystal RG, Simons M, Sato TN, Worgall S, Shido K, Rabbany SY, Rafii S. Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization. Cell. 2011;147:539–553. published online EpubOct 28. [PMC free article] [PubMed]
80. Ding BS, Nolan DJ, Butler JM, James D, Babazadeh AO, Rosenwaks Z, Mittal V, Kobayashi H, Shido K, Lyden D, Sato TN, Rabbany SY, Rafii S. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature. 2010;468:310–315. doi: 10.1038/nature09493. published online EpubNov 11. [PMC free article] [PubMed] [Cross Ref]
81. Bhushan B, Walesky C, Manley M, Gallagher T, Borude P, Edwards G, Monga SP, Apte U. Pro-regenerative signaling after acetaminophen-induced acute liver injury in mice identified using a novel incremental dose model. The American journal of pathology. 2014;184:3013–3025. doi: 10.1016/j.ajpath.2014.07.019. published online EpubNov. S0002-9440(14)00437-4 [pii] [PubMed] [Cross Ref]
82. Ding J, Yannam GR, Roy-Chowdhury N, Hidvegi T, Basma H, Rennard SI, Wong RJ, Avsar Y, Guha C, Perlmutter DH, Fox IJ, Roy-Chowdhury J. Spontaneous hepatic repopulation in transgenic mice expressing mutant human alpha1-antitrypsin by wild-type donor hepatocytes. The Journal of clinical investigation. 2011;121:1930–1934. doi: 10.1172/JCI45260. published online EpubMay. [PMC free article] [PubMed] [Cross Ref]
83. Fafalios A, Ma J, Tan X, Stoops J, Luo J, Defrances MC, Zarnegar R. A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism. Nature medicine. 2011;17:1577–1584. doi: 10.1038/nm.2531. published online EpubNov 13. [PMC free article] [PubMed] [Cross Ref]
84. Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, Sakakibara A, Adams S, Davy A, Deutsch U, Luthi U, Barberis A, Benjamin LE, Makinen T, Nobes CD, Adams RH. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature. 2010;465:483–486. published online EpubMay 27. [PubMed]
85. Martinez-Palacian A, del Castillo G, Suarez-Causado A, Garcia-Alvaro M, de Morena-Frutos D, Fernandez M, Roncero C, Fabregat I, Herrera B, Sanchez A. Mouse hepatic oval cells require Met-dependent PI3K to impair TGF-beta-induced oxidative stress and apoptosis. PloS one. 2013;8:e53108. doi: 10.1371/journal.pone.0053108. [PMC free article] [PubMed] [Cross Ref]
86. Fan-Minogue H, Cao Z, Paulmurugan R, Chan CT, Massoud TF, Felsher DW, Gambhir SS. Noninvasive molecular imaging of c-Myc activation in living mice. Proceedings of the National Academy of Sciences of the United States of America. 2010;107:15892–15897. doi: 10.1073/pnas.1007443107. published online EpubSep 7. [PubMed] [Cross Ref]
87. Kozower BD, Christofidou-Solomidou M, Sweitzer TD, Muro S, Buerk DG, Solomides CC, Albelda SM, Patterson GA, Muzykantov VR. Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nature biotechnology. 2003;21:392–398. published online EpubApr. [PubMed]
88. Oh P, Borgstrom P, Witkiewicz H, Li Y, Borgstrom BJ, Chrastina A, Iwata K, Zinn KR, Baldwin R, Testa JE, Schnitzer JE. Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nature biotechnology. 2007;25:327–337. published online EpubMar. [PMC free article] [PubMed]
89. Reynolds PN, Nicklin SA, Kaliberova L, Boatman BG, Grizzle WE, Balyasnikova IV, Baker AH, Danilov SM, Curiel DT. Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo. Nature biotechnology. 2001;19:838–842. published online EpubSep. [PubMed]
90. Morizono K, Xie Y, Ringpis GE, Johnson M, Nassanian H, Lee B, Wu L, Chen IS. Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. Nature medicine. 2005;11:346–352. published online EpubMar. [PubMed]
91. Yamamoto H, Yun EJ, Gerber HP, Ferrara N, Whitsett JA, Vu TH. Epithelial-vascular cross talk mediated by VEGF-A and HGF signaling directs primary septae formation during distal lung morphogenesis. Developmental biology. 2007;308:44–53. published online EpubAug 1. [PubMed]
92. Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure and implications for a central role in liver regeneration. J Gastroenterol Hepatol. 1991;6:509–519. published online EpubSep–Oct. [PubMed]
93. Huh CG, Factor VM, Sanchez A, Uchida K, Conner EA, Thorgeirsson SS. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:4477–4482. published online EpubMar 30. [PubMed]
94. Awuah PK, Nejak-Bowen KN, Monga SP. Role and regulation of PDGFRalpha signaling in liver development and regeneration. The American journal of pathology. 2013;182:1648–1658. doi: 10.1016/j.ajpath.2013.01.047. published online EpubMay. S0002-9440(13)00135-1 [pii] [PubMed] [Cross Ref]
95. Sancho P, Mainez J, Crosas-Molist E, Roncero C, Fernandez-Rodriguez CM, Pinedo F, Huber H, Eferl R, Mikulits W, Fabregat I. NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development. PloS one. 2012;7:e45285. doi: 10.1371/journal.pone.0045285. [PMC free article] [PubMed] [Cross Ref]
96. Cao Z, Ding BS, Guo P, Lee SB, Butler JM, Casey SC, Simons M, Tam W, Felsher DW, Shido K, Rafii A, Scandura JM, Rafii S. Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance. Cancer cell. 2014;25:350–365. published online EpubMar 17. [PMC free article] [PubMed]
97. Cao Z, Scandura JM, Inghirami GG, Shido K, Ding BS, Rafii S. Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem Cells. Cancer cell. 2017;31:110–126. doi: 10.1016/j.ccell.2016.11.010. published online EpubJan 09. [PMC free article] [PubMed] [Cross Ref]
98. Rafii S, Cao Z, Lis R, Siempos, Chavez D, Shido K, Rabbany SY, Ding BS. Platelet-derived SDF-1 primes the pulmonary capillary vascular niche to drive lung alveolar regeneration. Nature cell biology. 2015;17:123–136. published online EpubFeb. [PMC free article] [PubMed]
99. Hoot KE, Oka M, Han G, Bottinger E, Zhang Q, Wang XJ. HGF upregulation contributes to angiogenesis in mice with keratinocyte-specific Smad2 deletion. The Journal of clinical investigation. 2010;120:3606–3616. published online EpubOct 1. [PMC free article] [PubMed]
100. Degryse AL, Tanjore H, Xu XC, Polosukhin VV, Jones BR, McMahon FB, Gleaves LA, Blackwell TS, Lawson WE. Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis. American journal of physiology Lung cellular and molecular physiology. 2010;299:L442–452. published online EpubOct. [PubMed]